releases: http://susanwbrooks.house.gov/media-center/press-releases/brooks-statement-in-support-of-gabriella-miller-kids-first-research-act
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://susanwbrooks.house.gov/media-center/press-releases/brooks-statement-in-support-of-gabriella-miller-kids-first-research-act | Brooks Statement in Support of Gabriella Miller Kids First Research Act | 2013-12-11 | 2013 | 2013-12 | Republican | House | IN | Susan Brooks | B001284 | susanwbrooks.house.gov | legacy | Congresswoman Susan W. Brooks (R-IN5) praised passage of the Gabriella Miller Kids First Research Act in the U.S. House of Representatives today. The legislation ends taxpayer funding of political conventions and directs $126 million toward potentially groundbreaking pediatric research. “Our kids should always come first,” said Congresswoman Brooks. “The Gabriella Miller Kids First Research Act provides new levels of assistance for pediatric research that can help save lives. It enjoys widespread support from national children’s advocacy organizations as well as 5th District medical researchers, doctors, patients and parents. I am so glad the House chose to put our kids ahead of politics today. Senator Reid must allow a vote on this critical piece of legislation.” In July, Congresswoman Brooks joined Indiana University Health officials and family representatives of the Juvenile Diabetes Research Foundation and Leukemia and Lymphoma Society to urge passage of the bill during a gathering at Riley Hospital for Children. To learn more about this event, click here. "The Leukemia & Lymphoma Society is pleased to support the Kids First Research Act, which will provide much-needed additional resources for pediatric cancer research to the NIH,” said Amy Kwas, Executive Director of the Indiana Leukemia and Lymphoma Society. “While critical advances have been made in treatments for adult cancer, in 20 years, the FDA has approved only two drugs for childhood cancer, and half of all chemotherapies used for child cancers are over 25 years old. Sustained funding for researchers and health care professionals is crucial in the fight against pediatric cancers." Specifically, the bill terminates funding from the President Election Campaign Fund that is used to support party conventions. The funding will be directed to the National Institutes of Health (NIH) Common Fund to support transformative research aiming to find better treatments for childhood cancer, autism, Fragile X Syndrome and other pediatric diseases. The bill is named after Gabriella Miller, a 10 year-old cancer patient and advocate for pediatric research who passed away on October 26, 2013. To learn more about Gabriella’s story, click here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |